BANK OF AMERICA CORP /DE/ - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 37 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,943,297
+4.7%
5,632,0000.0%0.00%0.0%
Q2 2023$9,494,651
+163713.9%
5,632,000
+187633.3%
0.00%
Q1 2023$5,796
+210.3%
3,000
+200.0%
0.00%
Q4 2022$1,868
-6.6%
1,0000.0%0.00%
Q3 2022$2,000
-100.0%
1,000
-100.0%
0.00%
-100.0%
Q2 2022$9,920,000
+14.7%
7,920,000
+20.1%
0.00%0.0%
Q1 2022$8,650,000
+12810.4%
6,597,000
+14241.3%
0.00%
Q4 2021$67,000
-99.7%
46,000
-99.7%
0.00%
-100.0%
Q3 2021$23,639,000
-26.8%
15,986,000
-34.7%
0.00%
-33.3%
Q2 2021$32,274,000
+80.9%
24,485,000
+79.3%
0.00%
+50.0%
Q1 2021$17,836,000
+356620.0%
13,654,000
+682600.0%
0.00%
Q4 2020$5,000
-100.0%
2,000
-100.0%
0.00%
-100.0%
Q3 2020$11,249,000
-69.9%
5,425,000
-66.7%
0.00%
-66.7%
Q2 2020$37,427,000
-44.9%
16,308,000
-63.6%
0.01%
-50.0%
Q1 2020$67,961,000
+101.9%
44,773,000
+158.7%
0.01%
+140.0%
Q4 2019$33,662,000
-26.3%
17,307,000
-49.9%
0.01%
-28.6%
Q3 2019$45,676,000
+79.5%
34,573,000
+202.4%
0.01%
+75.0%
Q2 2019$25,447,000
-45.2%
11,432,000
-55.6%
0.00%
-42.9%
Q1 2019$46,473,00025,756,0000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders